文献速递前列腺癌

身体成分、身体功能与生活质量在健康男性及不同阶段前列腺癌中的比较

Body composition, physical function and quality of life in healthy men and across different stages of prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2021-01-25

本研究比较了激素敏感性前列腺癌(HSPC,n=43)、转移性去势抵抗性前列腺癌(mCRPC,n=22)及非癌症对照(CON,n=37)男性的身体成分、身体功能和生活质量。结果显示,mCRPC组绝对脂肪质量较CON组高约39%,TUG和椅子站立分别较CON和HSPC慢约71%和33%, stair climb较CON慢约29%,6米步行慢约18%。身体成分与身体功能相关(r=0.259-0.385),mCRPC组总体生活质量及多个子量表存在临床相关差异,但身体成分和功能未影响生活质量。

要点

  • mCRPC患者绝对脂肪质量较健康对照高约39%,身体功能显著下降。
  • mCRPC患者TUG和椅子站立较HSPC及对照慢约71%和33%。
  • 身体成分与身体功能相关,但未影响生活质量。

核心结论

  • 前列腺癌进展与身体成分和身体功能恶化相关,ARSI使用可能部分贡献于mCRPC组的变化。

研究设计与样本

  • 横断面比较研究,纳入激素敏感性前列腺癌43例、转移性去势抵抗性前列腺癌22例及非癌症对照37例。

主要发现

  • mCRPC组绝对脂肪质量较CON组高约39%。
  • mCRPC组TUG和椅子站立分别较CON和HSPC慢约71%和33%。
  • mCRPC组stair climb较CON慢约29%,6米步行慢约18%。
  • 身体成分与身体功能相关(r=0.259-0.385)。
  • mCRPC组总体生活质量及多个子量表较CON存在临床相关差异。

临床怎么用

  • 临床应关注前列腺癌进展患者的身体成分和功能下降,尤其mCRPC阶段。
  • 减少脂肪堆积的干预可能减轻激素治疗副作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Androgen deprivation therapy (ADT) for prostate cancer (PC) has detrimental effects on physical function and quality of life (QoL), but the addition of androgen receptor signalling inhibitors (ARSI) on these outcomes is unclear. PURPOSE: To compare body composition, physical function, and QoL across progressive stages of PC and non-cancer controls (CON). METHODS: In men with hormone sensitive PC (HSPC, n = 43) or metastatic castration-resistant PC (mCRPC, n = 22) or CON (n = 37), relative and absolute lean and fat mass, physical function (6 m walk, chair stands, timed up and go [TUG], stair climb), and QoL were determined. RESULTS: Relative body composition differed amongst all groups, along with ~39% greater absolute fat mass in mCRPC vs. CON. TUG and chair stands were ~71% and ~33% slower in mCRPC compared to both CON and HSPC, whereas stair climb was ~29% and 6 m walk was ~18% slower in mCRPC vs. CON. Relative body composition was correlated with physical function (r = 0.259-0.385). Clinically relevant differences for mCRPC were observed for overall QoL and several subscales vs. CON, although body composition and physical function did not influence QoL. CONCLUSIONS: PC progression is associated with deteriorations in body composition and physical function. As ADT length was similar between groups, ARSI use for mCRPC likely contributed in part to these changes. Given the difficulties of improving lean mass during ADT, interventions that reduce adiposity may lessen the side effects of hormone therapy.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Hanson ED, Stopforth CK, Alzer M, et al. Body composition, physical function and quality of life in healthy men and across different stages of prostate cancer. Prostate Cancer Prostatic Dis. 2021. PMID: 33495569. doi:10.1038/s41391-020-00317-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。